Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about FGF2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
FGF2 is a gene implicated in neurodegeneration research. Key relationships include: biomarker for, regulates, activates. Associated with ALS, ALZHEIMER'S DISEASE, Aging. Connected to 263 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | FGF2 |
| Full Name | Fibroblast Growth Factor 2 |
| Chromosome | 4q28 |
| Function | FGF2 (basic FGF) encodes a member of the fibroblast growth factor family that binds to FGFR1-4 with varying affinities. |
| Pathways | Akt, Mapk, Pi3K, Pi3K/Akt |
| UniProt ID | [P09038](https://www.uniprot.org/uniprot/P09038) |
| Ensembl ID | ENSG00000108639 |
| OMIM | 134760 |
| GeneCards | FGF2 |
| Human Protein Atlas | FGF2 |
| Associated Diseases | Aging, ALS, ANGIOGENESIS, Cancer, Carcinoma, CELL PROLIFERATION |
| Interactions | AND, ANGPT1, App, APP, AUTOPHAGY, Aβ |
| KG Connections | 479 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
FGF2["FGF2
Fibroblast Growth Factor 2"]
EGR1["EGR1
Early Growth Response 1"]
ANGPT1["ANGPT1
Angiopoietin 1"]
PDGFRB["PDGFRB
Platelet Derived Growth
Factor Receptor Beta"]
VEGFB["VEGFB
Vascular Endothelial
Growth Factor B"]
TLR4["TLR4
Toll-like Receptor 4"]
HSPA1A["HSPA1A
Heat Shock Protein
Family A Member 1A"]
Angiogenesis["Angiogenesis
Pathway"]
Fibroblast_Activation["Fibroblast
Activation"]
ALS["ALS
Amyotrophic Lateral
Sclerosis"]
Alzheimer["Alzheimer's
Disease"]
Neurodegeneration["Neurodegeneration"]
Neuroinflammation["Neuroinflammation"]
MS["Multiple
Sclerosis"]
EGR1 -->|"regulates"| FGF2
FGF2 -->|"activates"| EGR1
FGF2 -->|"activates"| ANGPT1
FGF2 -->|"activates"| PDGFRB
FGF2 -->|"activates"| VEGFB
FGF2 -->|"regulates"| TLR4
FGF2 -->|"regulates"| HSPA1A
FGF2 -->|"promotes"| Angiogenesis
FGF2 -->|"causes"| Fibroblast_Activation
FGF2 -->|"biomarker_for"| ALS
FGF2 -->|"biomarker_for"| Alzheimer
FGF2 -->|"biomarker_for"| Neurodegeneration
FGF2 -->|"biomarker_for"| Neuroinflammation
FGF2 -->|"inhibits"| MS
ANGPT1 --> Angiogenesis
VEGFB --> Angiogenesis
TLR4 --> Neuroinflammation
style FGF2 fill:#006494
style EGR1 fill:#4a1a6b
style ANGPT1 fill:#4a1a6b
style PDGFRB fill:#4a1a6b
style VEGFB fill:#4a1a6b
style TLR4 fill:#4a1a6b
style HSPA1A fill:#1b5e20
style Angiogenesis fill:#1b5e20
style MS fill:#1b5e20
style ALS fill:#ef5350
style Alzheimer fill:#ef5350
style Neurodegeneration fill:#ef5350
style Neuroinflammation fill:#ef5350
style Fibroblast_Activation fill:#5d4400| Target | Relation | Type | Str |
|---|---|---|---|
| angiogenesis | promotes | process | 0.95 |
| Angiogenesis | involved_in | process | 0.95 |
| Fibroblast Activation | associated_with | process | 0.90 |
| fibroblast activation | causes | phenotype | 0.90 |
| MAPK3 | activates | protein | 0.90 |
| MAPK1 | activates | protein | 0.90 |
| EGR1 | activates | protein | 0.90 |
| Endothelial Cells | expressed_in | cell_type | 0.85 |
| DNA synthesis | promotes | process | 0.85 |
| Amyloid Pathology | upregulates | process | 0.80 |
| stem cell proliferation | promotes | process | 0.80 |
| Amyloid Pathology | biomarker_for | process | 0.80 |
| Als | inhibits | disease | 0.75 |
| stem cells | expressed_in | cell_type | 0.70 |
| autophagy pathway | participates_in | pathway | 0.70 |
| ALS | regulates | disease | 0.65 |
| Inflammation | biomarker_for | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Carcinoma | implicated_in | disease | 0.65 |
| Aging | implicated_in | disease | 0.65 |
| CYTOKINES | interacts_with | phenotype | 0.65 |
| AXONAL DEGENERATION | interacts_with | phenotype | 0.65 |
| NEUROINFLAMMATION | causes | phenotype | 0.65 |
| Ms | regulates | disease | 0.65 |
| Neurodegeneration | biomarker_for | disease | 0.65 |
| Als | biomarker_for | disease | 0.65 |
| Neurodegeneration | protects_against | disease | 0.65 |
| Hypertension | inhibits | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Dementia | therapeutic_target | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Multiple Sclerosis | therapeutic_target | disease | 0.65 |
| Cancer | interacts_with | disease | 0.65 |
| Fibrosis | activates | disease | 0.65 |
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Alzheimer | biomarker_for | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Neuroinflammation | contributes_to | disease | 0.65 |
| Alzheimer | protects_against | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Neuroinflammation | biomarker_for | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| ANGIOGENESIS | interacts_with | phenotype | 0.65 |
| Tumor | implicated_in | disease | 0.65 |
| Cancer | implicated_in | disease | 0.65 |
| Als | contributes_to | disease | 0.65 |
| Inflammation | contributes_to | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ITGAV | binds | gene | 0.95 |
| EGR1 | upregulates | gene | 0.95 |
| ITGB3 | binds | gene | 0.95 |
| INTEGRIN ΑVΒ3 | interacts_with | receptor | 0.90 |
| EGR1 | regulates | protein | 0.90 |
| FGF2 mutant (K119E/R120E/K125E) | inhibits | protein | 0.88 |
| PI3K | associated_with | gene | 0.74 |
| ALZHEIMER'S DISEASE | associated_with | disease | 0.66 |
| BDNF | associated_with | gene | 0.66 |
| AKT | associated_with | gene | 0.66 |
| APOE | associated_with | gene | 0.66 |
| MICROGLIA | activates | cell_type | 0.65 |
| MICROGLIA | regulates | cell_type | 0.65 |
| PDGFRB | activates | gene | 0.60 |
| PARKINSON | regulates | gene | 0.60 |
| CSF2RA | regulates | gene | 0.60 |
| MIRNAS | expressed_in | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | regulates | gene | 0.60 |
| MAPK | activates | gene | 0.60 |
| S100A8 | regulates | gene | 0.60 |
| EGR1 | activates | gene | 0.60 |
| SQSTM1 | biomarker_for | gene | 0.60 |
| STAT3 | associated_with | gene | 0.60 |
| BDNF | biomarker_for | gene | 0.60 |
| PARKINSON'S DISEASE | regulates | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| BMP2 | activates | gene | 0.60 |
| VEGF | activates | gene | 0.60 |
| FGF1 | interacts_with | gene | 0.60 |
| ERK1 | activates | gene | 0.60 |
| P38 | regulates | gene | 0.60 |
| VEGFB | activates | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | regulates | gene | 0.60 |
| RAS | expressed_in | gene | 0.60 |
| FGFR1 | interacts_with | gene | 0.60 |
| HSPG2 | inhibits | gene | 0.60 |
| IL4 | activates | gene | 0.60 |
| ALZHEIMER | regulates | gene | 0.60 |
| CXCL10 | associated_with | gene | 0.60 |
| HSPA1A | regulates | gene | 0.60 |
| VEGFA | biomarker_for | gene | 0.60 |
| CXCL10 | regulates | gene | 0.60 |
| IL9 | activates | gene | 0.60 |
| CHIT1 | biomarker_for | gene | 0.60 |
| IRS1 | associated_with | gene | 0.60 |
| ANGPT1 | activates | gene | 0.60 |
| AKT | regulates | gene | 0.60 |
| APOE | biomarker_for | gene | 0.60 |
| NAMPT | regulates | gene | 0.60 |
| CSF2 | regulates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-02 | 5 hypotheses Top: 0.761
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning FGF2 in their description or question text
No additional research found